2023 - Research.com Medicine in Finland Leader Award
His primary areas of study are Breast cancer, Internal medicine, Cancer, Pathology and Genome-wide association study. His Breast cancer study incorporates themes from Single-nucleotide polymorphism, Genotype, Case-control study and Genetic predisposition. The various areas that Veli-Matti Kosma examines in his Internal medicine study include Endocrinology and Oncology.
His studies in Cancer integrate themes in fields like Survival rate, Cancer research and PALB2. His Pathology research focuses on subjects like Survival analysis, which are linked to Melanoma. His study in Genome-wide association study is interdisciplinary in nature, drawing from both TOX3, Disease, Genetic association and Bioinformatics.
His primary scientific interests are in Breast cancer, Internal medicine, Pathology, Oncology and Cancer. Veli-Matti Kosma has researched Breast cancer in several fields, including Single-nucleotide polymorphism, Genome-wide association study and Genotype. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Endocrinology.
As a part of the same scientific study, Veli-Matti Kosma usually deals with the Pathology, concentrating on Cancer research and frequently concerns with Carcinogenesis, Metastasis and Tumor suppressor gene. His Oncology research incorporates elements of Genetic predisposition, Case-control study, Ovarian cancer, Proportional hazards model and Gynecology. His Stromal cell study combines topics from a wide range of disciplines, such as Cancer cell, Stroma and CD44.
Veli-Matti Kosma mainly investigates Breast cancer, Oncology, Internal medicine, Genome-wide association study and Single-nucleotide polymorphism. His Breast cancer research is multidisciplinary, relying on both Genotype and Bioinformatics. His Oncology study integrates concerns from other disciplines, such as Odds ratio, Ovarian cancer, Proportional hazards model, Gynecology and Prospective cohort study.
Veli-Matti Kosma frequently studies issues relating to Pathology and Internal medicine. Veli-Matti Kosma has included themes like Genetic predisposition, Case-control study, Genotyping, Genetic association and Minor allele frequency in his Genome-wide association study study. The Single-nucleotide polymorphism study combines topics in areas such as Artificial intelligence, Haplotype and Candidate gene.
His scientific interests lie mostly in Breast cancer, Genome-wide association study, Internal medicine, Oncology and Genetics. His research in Breast cancer intersects with topics in Odds ratio, Case-control study, Genotype and Bioinformatics. The study incorporates disciplines such as Mendelian randomization, Genetic predisposition and Locus in addition to Genome-wide association study.
His Genetic predisposition research includes elements of MiRNA binding, microRNA and Genetic variation. His study focuses on the intersection of Internal medicine and fields such as Pathology with connections in the field of Cancer. His work deals with themes such as Tongue, Pancreatic cancer, Proportional hazards model, Stage and Risk factor, which intersect with Oncology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genome-wide association study identifies novel breast cancer susceptibility loci
Douglas F. Easton;Karen A. Pooley;Alison M. Dunning;Paul D. P. Pharoah.
Nature (2007)
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Kyriaki Michailidou;Per Hall;Anna Gonzalez-Neira;Maya Ghoussaini.
Nature Genetics (2013)
Association analysis identifies 65 new breast cancer risk loci
Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley.
Nature (2017)
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
Xiaohong R. Yang;Jenny Chang-Claude;Ellen L. Goode;Fergus J. Couch.
Journal of the National Cancer Institute (2011)
A common coding variant in CASP8 is associated with breast cancer risk
Angela Cox;Alison M. Dunning;Montserrat Garcia-Closas;Sabapathy Balasubramanian.
Nature Genetics (2007)
Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival.
Päivi Auvinen;Raija Tammi;Jyrki Parkkinen;Markku Tammi.
American Journal of Pathology (2000)
MicroRNA related polymorphisms and breast cancer risk
Sofia Khan;Dario Greco;Dario Greco;Kyriaki Michailidou;Roger L. Milne;Roger L. Milne.
PLOS ONE (2014)
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley.
Nature Genetics (2013)
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
Nasim Mavaddat;Kyriaki Michailidou;Kyriaki Michailidou;Joe Dennis;Michael Lush.
American Journal of Human Genetics (2019)
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
Kyriaki Michailidou;Jonathan Beesley;Sara Lindstrom;Sander Canisius.
Nature Genetics (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Melbourne
German Cancer Research Center
University of Eastern Finland
Cancer Council Victoria
German Cancer Research Center
Monash University
University of Copenhagen
University of Toronto
Heidelberg University
Mayo Clinic
Université Paris Cité
University of California, Berkeley
Donghua University
Chulalongkorn University
St Petersburg University
New Jersey Institute of Technology
University of California, Davis
University of Malaya
University of Dundee
International School for Advanced Studies
University of North Carolina at Chapel Hill
University of Edinburgh
University of Western Ontario
Lund University
Health Intervention and Technology Assessment Program
University of Edinburgh